Hospira, Inc. (HSP) Releases FY14 Earnings Guidance
Hospira, Inc. (NYSE:HSP) updated its FY14 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $2.30-2.50 for the period, compared to the Thomson Reuters consensus estimate of $2.43, American Banking and Market News reports.
A number of analysts have recently weighed in on HSP shares. Analysts at JPMorgan Chase & Co. reiterated a neutral rating on shares of Hospira in a research note on Thursday, July 31st. They now have a $55.00 price target on the stock, up previously from $42.00. On a related note, analysts at Zacks reiterated an outperform rating on shares of Hospira in a research note on Thursday, July 31st. They now have a $67.00 price target on the stock. Finally, analysts at Barclays reiterated an equal weight rating on shares of Hospira in a research note on Thursday, July 31st. They now have a $47.00 price target on the stock, up previously from $43.00. One research analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of $51.38.
Shares of Hospira, Inc. (NYSE:HSP) opened at 55.09 on Tuesday. Hospira, Inc. has a one year low of $38.11 and a one year high of $56.78. The stock’s 50-day moving average is $52.78 and its 200-day moving average is $47.43. The company has a market cap of $9.295 billion and a price-to-earnings ratio of 53.50.
Hospira (NYSE:HSP) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.16. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the company posted $0.55 earnings per share. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. Analysts expect that Hospira, Inc. will post $2.43 EPS for the current fiscal year.
In other Hospira news, CFO Thomas E. Werner unloaded 10,000 shares of Hospira stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $55.13, for a total transaction of $551,300.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Hospira, Inc (NYSE:HSP) is a provider of injectable drugs and infusion technologies.
Receive News & Ratings for Hospira Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hospira Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.